# OnCo record miltenyi-biomedicine (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/miltenyi-biomedicine/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "miltenyi-biomedicine" ;
  schema:name "Miltenyi Biomedicine"@en ;
  schema:alternateName "Miltenyi Biomedicine GmbH"@en ;
  schema:description "Miltenyi Biomedicine is a Germany-based cell therapy company running 5 late-stage cancer trials of zamtocabtagene autoleucel (MB-CART2019.1) and MB-CART2019.1 in diffuse large B-cell lymphoma, acute myeloid leukaemia and primary CNS lymphoma."@en ;
  schema:url <https://onco.cc/companies/miltenyi-biomedicine/>, <https://www.miltenyibiomedicine.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.miltenyibiomedicine.com>, <https://clinicaltrials.gov/search?lead=Miltenyi%20Biomedicine%20GmbH> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "DE" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/primary-cns-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/zamtocabtagene-autoleucel/> ;
  onco:trials <https://onco.cc/trials/nct04792489/>, <https://onco.cc/trials/nct07288879/>, <https://onco.cc/trials/nct04844866/>, <https://onco.cc/trials/nct06508931/> .